PERSPECTA

News from every angle

← Back to headlines

ImmunityBio Stock Loses 17% to Profit-Taking

ImmunityBio (IBRX) shares fell by 17% due to profit-taking after reaching an intra-day high.

26 Feb, 07:08 — 26 Feb, 07:08
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual44d ago

ImmunityBio (IBRX) Loses 17% to Profit-Taking After Intra-Day High

Read full article →

Related Stories

Oil Prices Rise After Previous Day's Sharp Drop

just now

Bank of Latvia Warns Abolishing Second Pension Pillar Requires Higher Labor Taxes

2h ago

IGIB ETF Offers Broader Bond Exposure Compared to FIGB

2h ago

Montenegrin Parliamentary Parties Spent Nearly €700,000 Last Year

2h ago